Cluster Subanalysis of Patients With Severe Asthma Who Responded to Omalizumab

J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):213-215. doi: 10.18176/jiaci.0731. Epub 2021 Sep 28.

I Dávila^{1

2}, P Campo³, S Cimbollek⁴, C Almonacid Sánchez⁵, S Quirce^{6

7}, A Moreira⁸, A Ramirez⁸, G Soto Campos⁹

¹ Allergy Service, University Hospital of Salamanca and Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
² Biomedical and Diagnosis Science Department, Salamanca University School of Medicine, Salamanca, Spain.
³ Allergy Unit, IBIMA-Regional University Hospital of Málaga, Málaga, Spain.
⁴ Department of Allergy, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
⁵ Department of Respiratory Medicine, Ramón y Cajal Hospital, IRYCIS, Alcala de Henares University, Madrid, Spain.
⁶ Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
⁷ CIBER de Enfermedades Respiratorias, CIBERES, Madrid, Spain.
⁸ Novartis Farmacéutica, Barcelona, Spain.
⁹ Pneumology and Allergy Unit, Hospital Universitario de Jerez, Cádiz, Spain.

No abstract available

Keywords: Allergens and epitopes; Asthma; Eosinophils; IgE.

Publication types